IRWD vs SIGA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
IRWD Captures Institutional Edge (2โ2 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ironwood Pharmaceuticals, Inc. - Class A (IRWD) driven by superior Growth & Margin, Momentum & Technical while SIGA counters with relative strength in Valuation, Options & Structure. Fundamentally, IRWD trades at 12.3x Forward P/E with 62.9% operating margin (+9.0% YoY revenue) versus SIGA at 2.5x Forward P/E and -14.2% operating margin (-49.7% YoY). In options structure, IRWD sits in CONSOLIDATION (14th %ile IV; Dealer Gamma Walls on Pro) against SIGA sits in CONSOLIDATION (8th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | IRWD Revenue | SIGA Revenue | IRWD Op. Margin | SIGA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $350M | $480M | -43.5% | 74.4% | SIGA |
| FY2019 | $430M | $30M | 28.0% | -8.7% | IRWD |
| FY2020 | $390M | $120M | 36.7% | 67.6% | SIGA |
| FY2021 | $410M | $130M | 56.1% | 66.7% | SIGA |
| FY2022 | $410M | $110M | 61.0% | 38.5% | IRWD |
| FY2023 | $440M | $140M | -213.5% | 59.8% | SIGA |
| FY2024 | $350M | $140M | 26.5% | 50.4% | SIGA |
| FY2025 | $300M | $90M | 33.3% | 25.1% | IRWD |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | IRWD | SIGA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $791.3M | $187.9M | Larger Scale | IRWD |
| Trailing P/E Ratio Valuation | 5.3x | N/M | Lower Multiple | IRWD |
| Forward P/E Ratio Valuation | 12.3x | 2.5x | Lower Multiple | SIGA |
| Revenue Growth (YoY) Growth | +9.0% | -49.7% | Higher Growth | IRWD |
| Operating Margin (TTM) Profitability | 62.9% | -14.2% | Higher Margin | IRWD |
| Net Profit Margin Profitability | 37.4% | 1.3% | Higher Margin | IRWD |
| Return on Equity (ROE) Capital Efficiency | -574.7% | 0.4% | Higher ROE | SIGA |
| 52-Week Range Position Momentum | 62% ($3โ$6) | 3% ($3โ$7) | Stronger Trend | IRWD |
| Beta / 30D Volatility Risk Regime | 1.31ฮฒ ยท 54% Vol | 0.75ฮฒ ยท 65% Vol | Lower Realized Risk | IRWD |
| Unified Institutional Score Composite Signal | 37.5 / 100 (SELL) | 47.5 / 100 (HOLD) | Higher Composite | SIGA |